TGM2 and celiac disease: One year later, selective gliadin deamidation by TG2 resulting in recognition of the respective modified peptides by gut-derived DQ2-restricted T-cells was shown, thus providing insight into the fundamental molecular interplay between TG2 activity, gluten, and the genetic background that leads to activation of the immune system in celiac disease [11,12].